zone2

secondary-storefront-menu

International

North America

China

Japan

Latin America

Brazil

Region

Set your region:

products

%1 products have been added to your cart but %2 have been backordered and will be fulfilled when stock is available

Product on backorder

Current quantity limit is [maxProductQuantity], please, navigate to the cart page and change quantity of product

You will be able to resubmit promo in ${countdown} seconds. test

Please note that the taxes displayed on our website are estimated and subject to adjustment. The actual tax charges will be determined and settled during the final invoicing of your order

product-detail-component

Marketing materials, training documents, discovery services

cengage:card

FIND YOUR SALES REPRESENTATIVE

cengage:column

Get marketing materials, training documents, discovery services.

PRODUCT SUPPORT

CUSTOMER SUPPORT

Report technical issues, errors, check system status

TECHNICAL SUPPORT

Manage product preferences, generate usage reports, simplify administrative tasks.

ADMIN TOOLS

support

cengage:galethorndikeseo

header-component

secondary-account-menu

Profile

Orders

Wish List

Fast Order Entry

My Account

zone3

header

footer-menu-component

footer-legal-menu

Terms of use

Privacy

container

mega-menu

Browse by Institution Type

Browse by Product Type

Products

Support

secondary-primary-menu

About Us

Blogs

Press Center

Events

News

Careers

Our Company

Request a Trial

footer

gale-footer

config

FIND YOUR REP

support-order-2

footer-menu

Academic Institutions

K-12

Public Libraries

Government and Special Libraries

Statewide Programs

Institutions

Databases

Primary Sources

Digital Humanities Tools

eLearning

Schools/K-12 Curriculum

Books

Large Print Books by Thorndike Press

Find Your Rep

Product Support

Technical Support

Customer Support

Admin Tools

Accessibility Policy

Partnerships

Contact Us

Would you like to go to the Gale {{RECOMMENDED_COUNTRY}} site instead?

It looks like you're visiting from {{DETECTED_COUNTRY}}.

main

Account Information

bundle-connector

footer-legal-menu-component

You may already have access to Gale content through your institution.

STUDENTS AND RESEARCHERS

zone1

single-column

support-order-1

footer-social-menu

Sign Up for Emails

CONNECT WITH GALE

Stay up-to-date with the latest Gale news, exclusive offers, and more.

facebook

linkedin

instagram

youtube

SOCIAL ICONS

footer-social-menu-component

CLNCL TRLS: STDY DSGN ENDPT BIOMRK DRG SFTY FDA GDLNS 2

Drugs & Pharmacology

Health, Medicine & Nursing

Gt Product Group

Binding Format

Marketing Imprint Name

B2B GT

CL Carton Count

Imprint Name

B2B & B2C

<P>This practical guide takes an integrated approach to incorporate biomedical science, laboratory data of human study, endpoint specification, legal and regulatory aspects with the fundamentals of clinical trial design. It provides an overview of the design options along with the specific details of trial design and offers guidance on how to make appropriate choices.</P>

Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines

College Freshman

College Sophomore

College Junior

College Senior

Clinical Trials

Duration

Duration Unit Of Measure

Transaction Type

Front Cover.
Half Title Page.
Title Page.
Copyright Page.
Dedication.
Contents.
Acknowledgments.
Preface.
Introduction.
Abbreviations and Definitions.
Biographies.
1: Origins of Drugs.
2: Clinical Trial Design.
3: Run-in Period.
4: Inclusion/Exclusion Criteria, Stratification, and Subgroups&#x2014;Part I.
5: Inclusion/Exclusion Criteria, Stratification, and Subgroups&#x2014;Part II.
6: Blinding, Randomization, and Allocation.
7: Placebo Arm as Part of Clinical Trial Design.
8: Intent-to-Treat Analysis Versus Per Protocol Analysis.
9: Biostatistics&#x2014;Part I.
10: Biostatistics&#x2014;Part II.
11: Introduction to Endpoints.
12: Oncology Endpoint&#x2014;Objective Response.
13: Oncology Endpoints: Overall Survival and Progression-Free Survival.
14: Oncology Endpoints: Time to Progression.
15: Oncology Endpoint: Disease-Free Survival.
16: Oncology Endpoint: Time to Distant Metastasis.
17: Neoadjuvant Therapy Versus Adjuvant Therapy.
18: Hematological Cancers.
19: Biomarkers.
20: Endpoints for Immune Diseases.
21: Endpoints for Infections.
22: Health-Related Quality of Life Tools&#x2014;Oncology.
23: Health-Related Quality-of-Life Tools&#x2014;Immune Disorders.
24: Health-Related Quality-of-Life Tools&#x2014;Infections.
25: Drug Safety.
26: Mechanism of Action of Diseases and Drugs&#x2014;Part I.
27: Mechanism of Action&#x2014;Part II (Cancer).
28: Mechanism of Action&#x2014;Part III (Immune Disorders).
29: Mechanisms of Action&#x2014;Part IV (Infections).
30: Consent Forms.
31: Package Inserts.
32: Warning Letters.
33: Regulatory Approval.
34: Patents.
Index.

Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines.css-1p8rvzy{position:absolute;padding-left:8px;}

Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines